Cargando…
Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence
Gestational diabetes mellitus (GDM) is the fastest growing type of diabetes, affecting between 2 to 38% of pregnancies worldwide, varying considerably depending on diagnostic criteria used and sample population studied. Adverse obstetric outcomes include an increased risk of macrosomia, and higher r...
Autores principales: | Alesi, Simon, Ghelani, Drishti, Rassie, Kate, Mousa, Aya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197243/ https://www.ncbi.nlm.nih.gov/pubmed/34073737 http://dx.doi.org/10.3390/ijms22115512 |
Ejemplares similares
-
Vitamin D and COVID-19: An Overview of Recent Evidence
por: Ghelani, Drishti, et al.
Publicado: (2021) -
Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
por: Rassie, Kate, et al.
Publicado: (2022) -
Mobile Apps for Weight Management: A Review of the Latest Evidence to Inform Practice
por: Ghelani, Drishti P., et al.
Publicado: (2020) -
Prolactin in Pregnancies Affected by Pre-Existing Maternal Metabolic Conditions: A Systematic Review
por: Rassie, Kate, et al.
Publicado: (2023) -
Current progress in metabolomics of gestational diabetes mellitus
por: Wang, Qian-Yi, et al.
Publicado: (2021)